Product Sales Data From Annual Reports of Major Pharmaceutical Companies 2016

S. No.	Company Name	Product Name	Active Ingredient	Main Therapeutic Indication	Currency	Unit	2016 Revenue in Millions	2015 Revenue in Millions	2016 Revenue in Millions (USD)	2015 Revenue in Millions (USD)	Sales Difference in Millions (USD)	Growth (%)
1	Abbvie	Humira	Adalimumab	Immunology (Organ Transplant, Arthritis etc.)	USD	Millions	16,078	14,012	16,078	14,012	2,066	15
2	Abbvie	Androgel	Testosterone	Hormonal Disorders	USD	Millions	675	694	675	694	-19	-3
3	Abbvie	Kaletra	Lopinavir/Ritonavir	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	549	700	549	700	-151	-22
4	Abbvie	Synagis	Palivizumab	Respiratory Disorders	USD	Millions	730	740	730	740	-10	-1
5	Abbvie	Lupron	Leuprolide Acetate	Oncology	USD	Millions	821	826	821	826	-5	-1
6	Abbvie	Synthroid	Levothyroxine Sodium	Hormonal Disorders	USD	Millions	763	755	763	755	8	1
7	Abbvie	Sevoflurane	Sevoflurane	Anesthetics	USD	Millions	428	474	428	474	-46	-10
8	Abbvie	Creon	Pancrelipase	Rare Diseases	USD	Millions	730	632	730	632	98	16
9	Abbvie	Duodopa	Carbidopa/Levodopa	Neurological/Mental Disorders	USD	Millions	293	231	293	231	62	27
10	Abbvie	Viekira Pak	Ombitasvir/Paritaprevir/Ritonavir	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	1,522	1,639	1,522	1,639	-117	-7
11	Abbvie	Imbruvica	Ibrutinib	Oncology	USD	Millions	1,832	754	1,832	754	1,078	143
12	Abbvie	Others			USD	Millions	1,139	1,402	1,139	1,402	-263	-19
13	Abbvie	Total Pharmaceuticals			USD	Millions	25,560	22,859	25,560	22,859	2,701	12
14	Abbvie	Other Revenues			USD	Millions	78	Not Reported	78	Not Reported	78	Not Reported
15	Abbvie	Total Sales			USD	Millions	25,638	22,859	25,638	22,859	2,779	12
16	Abbott			Pediatric	USD	Millions	3,883	3,970	3,883	3,970	-87	-2
17	Abbott			Adult	USD	Millions	3,016	3,005	3,016	3,005	11	0
18	Abbott	Total Nutrition			USD	Millions	6,899	6,975	6,899	6,975	-76	-1
19	Abbott			Core Laboratory	USD	Millions	3,844	3,707	3,844	3,707	137	4
20	Abbott			Molecular	USD	Millions	456	466	456	466	-10	-2
21	Abbott			Point of Care	USD	Millions	513	473	513	473	40	8
22	Abbott	Total Diagnostics			USD	Millions	4,813	4,646	4,813	4,646	167	4
23	Abbott	Key Emerging Markets			USD	Millions	2,912	2,781	2,912	2,781	131	5
24	Abbott	Others			USD	Millions	947	939	947	939	8	1
25	Abbott	Total Established Pharmaceuticals			USD	Millions	3,859	3,720	3,859	3,720	139	4
26	Abbott			Vascular	USD	Millions	2,896	2,792	2,896	2,792	104	4
27	Abbott			Diabetes	USD	Millions	1,142	1,117	1,142	1,117	25	2
28	Abbott			Medical Optics	USD	Millions	1,195	1,133	1,195	1,133	62	5
29	Abbott	Total Medical Devices			USD	Millions	5,233	5,042	5,233	5,042	191	4
30	Abbott	Other Sales			USD	Millions	49	22	49	22	27	123
31	Abbott	Total Sales			USD	Millions	20,853	20,405	20,853	20,405	448	2
32	Actelion	Opsumit	Macitentan	Cardiovascular Diseases	CHF	Millions	831	516	823	511	312	61
33	Actelion	Tracleer	Bosentan	Cardiovascular Diseases	CHF	Millions	1,020	1,212	1,010	1,200	-190	-16
34	Actelion	Uptravi	Selexipag	Cardiovascular Diseases	CHF	Millions	245	Not Reported	243	Not Reported	243	New Launch
35	Actelion	Veletri	Epoprostenol	Cardiovascular Diseases	CHF	Millions	97	83	96	82	14	17
36	Actelion	Ventavis	Iloprost	Cardiovascular Diseases	CHF	Millions	73	105	72	104	-32	-30
37	Actelion	Valchlor	Mechlorethamine	Oncology	CHF	Millions	35	27	35	27	8	30
38	Actelion	Zavesca	Miglustat	Rare Diseases	CHF	Millions	104	92	103	91	12	13
39	Actelion	Others			CHF	Millions	8	7	8	7	1	14
40	Actelion	Total Pharmaceutical Sale			CHF	Millions	2,412	2,042	2,388	2,022	366	18
41	Actelion	Contract Revenue			CHF	Millions	6	4	6	4	2	50
42	Actelion	Total Sale			CHF	Millions	2,418	2,046	2,394	2,026	368	18
43	Alexion	Soliris	Eculizumab	Blood Disorders	USD	Millions	2,843	2,591	2,843	2,591	252	10
44	Alexion	Strensiq	Asfotase Alfa	Metabolic Disorders	USD	Millions	210	12	210	12	198	1,650
45	Alexion	Kanuma	Sebelipase Alfa	Metabolic Disorders	USD	Millions	29	Not Reported	29	Not Reported	29	New Launch
46	Alexion	Others			USD	Millions	2	1	2	1	1	100
47	Alexion	Total Net Product Sales			USD	Millions	3,084	2,604	3,084	2,604	480	18
48	Allergan	Botox	Onabotulinumtoxina	Urology	USD	Millions	2,786	1,971	2,786	1,971	815	41
49	Allergan	Restasis	Cyclosporine	Immunology (Organ Transplant, Arthritis etc.)	USD	Millions	1,488	1,048	1,488	1,048	440	42
50	Allergan	Fillers			USD	Millions	867	574	867	574	293	51
51	Allergan	Lumigan/Ganfort	Bimatoprost	Ophthalmology	USD	Millions	688	544	688	544	144	26
52	Allergan	Linzess/Constella	Linaclotide	Gastrointestinal Disorders	USD	Millions	643	459	643	459	184	40
53	Allergan	Bystolic/Byvalson	Nebivolol	Cardiovascular Diseases	USD	Millions	641	646	641	646	-5	-1
54	Allergan	Namenda XR	Memantine Hydrochloride	Alzheimer Diseases	USD	Millions	628	759	628	759	-131	-17
55	Allergan	Alphagan/Combigan	Brimonidine Tartrate/Timolol Maleate	Ophthalmology	USD	Millions	546	411	546	411	135	33
56	Allergan	Eye Drops		Ophthalmology	USD	Millions	463	398	463	398	65	16
57	Allergan	Asacol/Delzicol	Mesalazine	Gastrointestinal Disorders	USD	Millions	415	618	415	618	-203	-33
58	Allergan	Lo Loestrin	Norethindrone Acetate/Ethinyl Estradiol	Contraception	USD	Millions	404	350	404	350	54	15
59	Allergan	Estracecream	Estradiol	Reproductive System Diseases	USD	Millions	379	326	379	326	53	16
60	Allergan	Breast Implants			USD	Millions	356	301	356	301	55	18
61	Allergan	Viibryd/Fetzima	Vilazodone	Neurological/Mental Disorders	USD	Millions	342	328	342	328	14	4
62	Allergan	Minastrin24	Ethinyl Estradiol, Norethindrone	Contraception	USD	Millions	327	273	327	273	54	20
63	Allergan	Ozurdex	Dexamethasone	Ophthalmology	USD	Millions	263	168	263	168	95	57
64	Allergan	Carafate/Sulcrate	Sucralfate	Gastrointestinal Disorders	USD	Millions	231	213	231	213	18	8
65	Allergan	Aczone	Dapsone	Dermatology	USD	Millions	217	171	217	171	46	27
66	Allergan	Zenpep	Pancrelipase	Gastrointestinal Disorders	USD	Millions	201	167	201	167	34	20
67	Allergan	Canasa/Salofalk	Mesalazine	Gastrointestinal Disorders	USD	Millions	196	156	196	156	40	26
68	Allergan	Saphris	Asenapine	Neurological/Mental Disorders	USD	Millions	167	187	167	187	-20	-11
69	Allergan	Armour Thyroid	Thyroid Extract	Hypothyroidism	USD	Millions	167	131	167	131	36	27
70	Allergan	Teflaro	Ceftaroline	Dermatology	USD	Millions	134	138	134	138	-4	-3
71	Allergan	Rapaflo	Silodosin	Renal Disorders	USD	Millions	122	126	122	126	-4	-3
72	Allergan	Skinmedica		Dermatology	USD	Millions	108	77	108	77	31	40
73	Allergan	Savella	Milnacipran Hcl	Fibromyalgia	USD	Millions	103	106	103	106	-3	-3
74	Allergan	Tazorac	Tazarotene	Dermatology	USD	Millions	96	94	96	94	2	2
75	Allergan	Vraylar	Cariprazine	Neurological/Mental Disorders	USD	Millions	94	Not Reported	94	Not Reported	94	New Launch
76	Allergan	Viberzi	Eluxadoline	Gastrointestinal Disorders	USD	Millions	93	12	93	12	81	675
77	Allergan	Latisse	Bimatoprost	Hypotrichosis of Eyelashes	USD	Millions	86	73	86	73	13	18
78	Allergan	Lexapro	Escitalopram Oxalate	Neurological/Mental Disorders	USD	Millions	67	72	67	72	-5	-7
79	Allergan	Namzaric	Memantine And Donepezil Hydrochloride	Neurological/Mental Disorders	USD	Millions	58	11	58	11	47	427
80	Allergan	Kybella/Belkyra	Deoxycholic Acid	Submental Fat	USD	Millions	53	3	53	3	50	1,667
81	Allergan	Dalvance	Dalbavancin	Dermatology	USD	Millions	39	17	39	17	22	129
82	Allergan	Avycaz	Ceftazidime And Avibactam	Gastrointestinal Disorders	USD	Millions	36	23	36	23	13	57
83	Allergan	Liletta	Levonorgestrel	Contraception	USD	Millions	23	15	23	15	8	53
84	Allergan	Enablex	Darifenacin	Renal Disorders	USD	Millions	17	69	17	69	-52	-75
85	Allergan	Namenda IR	Memantine Hydrochloride	Alzheimer Diseases	USD	Millions	15	556	15	556	-541	-97
86	Allergan	Other Revenues			USD	Millions	1,091	1,256	1,091	1,256	-165	-13
87	Allergan	Less Product Sold Through Our Former ANDA Distribution Business			USD	Millions	-80	-157	-80	-157	77	-49
88	Allergan	Total Net Revenues			USD	Millions	14,571	12,688	14,571	12,688	1,883	15
89	Amgen	Neulasta	Pegfilgrastim	Blood Disorders	USD	Millions	4,648	4,715	4,648	4,715	-67	-1
90	Amgen	Neupogen	Filgrastim	Blood Disorders	USD	Millions	765	1,049	765	1,049	-284	-27
91	Amgen	Enbrel	Etanercept	Immunology (Organ Transplant, Arthritis etc.)	USD	Millions	5,965	5,364	5,965	5,364	601	11
92	Amgen	Xgeva	Denosumab	Oncology	USD	Millions	1,529	1,405	1,529	1,405	124	9
93	Amgen	Prolia	Denosumab	Bone Health	USD	Millions	1,635	1,312	1,635	1,312	323	25
94	Amgen	Epogen	Epoetin Alfa	Blood Disorders	USD	Millions	1,282	1,856	1,282	1,856	-574	-31
95	Amgen	Aranesp	Darbepoetin Alfa	Blood Disorders	USD	Millions	2,093	1,951	2,093	1,951	142	7
96	Amgen	Sensipar/ Mimpara	Cinacalcet	Hormonal Disorders	USD	Millions	1,582	1,415	1,582	1,415	167	12
97	Amgen	Vectibix	Panitumumab	Oncology	USD	Millions	611	549	611	549	62	11
98	Amgen	Nplate	Romiplostim	Immunology (Organ Transplant, Arthritis etc.)	USD	Millions	584	525	584	525	59	11
99	Amgen	Kyprolis	Carfilzomib	Oncology	USD	Millions	692	512	692	512	180	35
100	Amgen	Blincyto	Blinatumomab	Oncology	USD	Millions	115	77	115	77	38	49
101	Amgen	Repatha	Evolocumab	Cardiovascular Diseases	USD	Millions	141	10	141	10	131	1,310
102	Amgen	Others			USD	Millions	250	204	250	204	46	23
103	Amgen	Total Pharmaceuticals			USD	Millions	21,892	20,944	21,892	20,944	948	5
104	Amgen	Other Revenues			USD	Millions	1,099	718	1,099	718	381	53
105	Amgen	Total Revenues			USD	Millions	22,991	21,662	22,991	21,662	1,329	6
106	Astellas	Symbicort	Budesonide and Formoterol	Respiratory Disorders	Yen	Millions	38,400	36,900	346	332	14	4
107	Astellas	Xtandi	Enzalutamide	Oncology	Yen	Millions	253,200	231,100	2,279	2,080	199	10
108	Astellas	Lipitor	Atorvastatin Calcium	Cardiovascular Diseases	Yen	Millions	24,600	34,700	221	312	-91	-29
109	Astellas	Prograf	Tacrolimus	Immunology (Organ Transplant, Arthritis etc.)	Yen	Millions	188,300	204,400	1,695	1,840	-145	-8
110	Astellas	Vesicare	Solifenacin Succinate	Urology	Yen	Millions	120,100	135,800	1,081	1,222	-141	-12
111	Astellas	Ambisome	Amphotericin B	Infectious Diseases (HIV, Hepatitis etc.)	Yen	Millions	10,500	10,600	95	95	-1	-1
112	Astellas	Micardis	Telmisartan	Cardiovascular Diseases	Yen	Millions	93,700	97,500	843	878	-34	-4
113	Astellas	Betanis/Myrbetriq/Betmiga	Mirabegron	Renal Disorders	Yen	Millions	93,200	75,400	839	679	160	24
114	Astellas	Seroquel	Quetiapine Fumarate	Neurological/Mental Disorders	Yen	Millions	8,000	11,100	72	100	-28	-28
115	Astellas	Adenoscan/Lexiscan	Adenosine/Regadenoson	Diagnostic	Yen	Millions	69,900	75,800	629	682	-53	-8
116	Astellas	Myslee	Zolpidem	Sleep Disorders	Yen	Millions	15,300	18,500	138	167	-29	-17
117	Astellas	celecox	Celecoxib	Anti-Inflammatory	Yen	Millions	47,600	46,400	428	418	11	3
118	Astellas	Harnal/Omnic	Tamsulosin	Renal Disorders	Yen	Millions	47,300	54,900	426	494	-68	-14
119	Astellas	Funguard/Mycamine	Micafungin sodium	Anti-fungal	Yen	Millions	40,300	41,000	363	369	-6	-2
120	Astellas	Tarceva	Erlotinib	Oncology	Yen	Millions	36,800	49,200	331	443	-112	-25
121	Astellas	Vaccines	Vaccines	Vaccines	Yen	Millions	34,100	43,900	307	395	-88	-22
122	Astellas	Eligard	Leuprorelin	Oncology	Yen	Millions	16,000	18,100	144	163	-19	-12
123	Astellas	Protopic	Tacrolimus	Immunology	Yen	Millions	3,500	15,800	32	142	-111	-78
124	Astellas	Bonoteo	Minodronic acid	Oesteoprosis	Yen	Millions	13,900	14,200	125	128	-3	-2
125	Astellas	Gaster	Famotidine	Gastrointestinal Disorders	Yen	Millions	11,400	15,600	103	140	-38	-27
126	Astellas	Geninax	Garenoxacin	Anti-Bacterial	Yen	Millions	10,100	10,900	91	98	-7	-7
127	Astellas	Suglat	Ipragliflozin	Diabetes	Yen	Millions	9,100	6,300	82	57	25	44
128	Astellas	Cimzia	Certolizumab pegol	Anti-Inflammatory	Yen	Millions	7,600	6,200	68	56	13	23
129	Astellas	Argamate	Calcium polystyrene sulphonate	Hyperkalemia	Yen	Millions	5,900	6,100	53	55	-2	-3
130	Astellas	Cresemba	Isavuconazonium sulfate	Anti-fungal	Yen	Millions	5,000	1,590	45	14	31	214
131	Astellas	Gonax	Degarelix acetate	Oncology	Yen	Millions	4,300	3,800	39	34	5	13
132	Astellas	Dificlir	Fidaxomicin	Infectious Diseases (HIV, Hepatitis etc.)	Yen	Millions	2,200	2,500	20	23	-3	-12
133	Astellas	Qutenza	Capasaicin	Neuropathic pain	Yen	Millions	2,000	2,100	18	19	-1	-5
134	Astellas	Kiklin	Bixalomer	Renal Disorders	Yen	Millions	1,600	1,500	14	14	1	7
135	Astellas	Cefzon			Yen	Millions	Not Reported	1,100	Not Reported	10	-10	-100
136	Astellas	Total Sales			Yen	Millions	1,312,600	1,360,200	11,813	12,242	-428	-3
137	AstraZeneca	Crestor	Rosuvastatin Calcium	Cardiovascular Diseases	USD	Millions	3,401	5,017	3,401	5,017	-1,616	-32
138	AstraZeneca	Seloken/Toprol-XL	Metoprolol Hydrochloride	Cardiovascular Diseases	USD	Millions	737	710	737	710	27	4
139	AstraZeneca	Onglyza/Kombiglyze XR/Komboglyze	Saxagliptin/Saxagliptin+Metoprolol Hydrochloride	Diabetes	USD	Millions	720	786	720	786	-66	-8
140	AstraZeneca	Atacand	Candesartan	Cardiovascular Diseases	USD	Millions	315	358	315	358	-43	-12
141	AstraZeneca	Brilinta/Brilique	Ticagrelor	Cardiovascular Diseases	USD	Millions	839	619	839	619	220	36
142	AstraZeneca	Byetta	Exenatide	Diabetes	USD	Millions	254	316	254	316	-62	-20
143	AstraZeneca	Bydureon	Exenatide	Diabetes	USD	Millions	578	580	578	580	-2	0
144	AstraZeneca	Farxiga/Forxiga	Dapagliflozin	Diabetes	USD	Millions	835	492	835	492	343	70
145	AstraZeneca	Plendil, Tenormin and others	Felodipine, Atenolol	Cardiovascular Diseases	USD	Millions	437	611	437	611	-174	-28
146	AstraZeneca	Total Cardiovascular And Metabolic Diseases			USD	Millions	8,116	9,489	8,116	9,489	-1,373	-14
147	AstraZeneca	Zoladex	Goserelin Acetate	Oncology	USD	Millions	816	816	816	816	0	0
148	AstraZeneca	Faslodex	Fulvestrant	Oncology	USD	Millions	830	704	830	704	126	18
149	AstraZeneca	Iressa	Gefitinib	Oncology	USD	Millions	513	543	513	543	-30	-6
150	AstraZeneca	Arimidex	Anastrozole	Oncology	USD	Millions	232	250	232	250	-18	-7
151	AstraZeneca	Casodex	Bicalutamide	Oncology	USD	Millions	247	267	247	267	-20	-7
152	AstraZeneca	Lynparza	Olaparib	Oncology	USD	Millions	218	94	218	94	124	132
153	AstraZeneca	Tagrisso	Osimertinib	Oncology	USD	Millions	423	19	423	19	404	2,126
154	AstraZeneca	Other Products			USD	Millions	104	132	104	132	-28	-21
155	AstraZeneca	Total Oncology			USD	Millions	3,383	2,825	3,383	2,825	558	20
156	AstraZeneca	Symbicort	Budesonide And Formoterol	Respiratory Disorders	USD	Millions	2,989	3,394	2,989	3,394	-405	-12
157	AstraZeneca	Pulmicort	Budesonide	Respiratory Disorders	USD	Millions	1,061	1,014	1,061	1,014	47	5
158	AstraZeneca	Tudorza/Eklira	Aclidinium Bromide	Respiratory Disorders	USD	Millions	170	190	170	190	-20	-11
159	AstraZeneca	Daliresp/Daxas	Roflumilast	Respiratory Disorders	USD	Millions	154	104	154	104	50	48
160	AstraZeneca	Duaklir	Aclidinium Bromide/Formoterol Fumarate	Respiratory Disorders	USD	Millions	63	27	63	27	36	133
161	AstraZeneca	Other Products			USD	Millions	316	258	316	258	58	22
162	AstraZeneca	Total Respiratory, Inflammation And Autoimmunity			USD	Millions	4,753	4,987	4,753	4,987	-234	-5
163	AstraZeneca	Synagis	Palivizumab	Respiratory Disorders	USD	Millions	677	662	677	662	15	2
164	AstraZeneca	Flumist/Fluenz	Influenza Vaccine Live, Intranasal	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	104	288	104	288	-184	-64
165	AstraZeneca	Movantik/Moventig	Naloxegol	Gastrointestinal Disorders	USD	Millions	91	29	91	29	62	214
166	AstraZeneca	Seroquel XR	Quetiapine Fumarate	Neurological/Mental Disorders	USD	Millions	735	1,025	735	1,025	-290	-28
167	AstraZeneca	Nexium	Esomeprazole Magnesium	Gastrointestinal Disorders	USD	Millions	2,032	2,496	2,032	2,496	-464	-19
168	AstraZeneca	Losec/Prilosec	Omeprazole	Gastrointestinal Disorders	USD	Millions	276	340	276	340	-64	-19
169	AstraZeneca	Local Anaesthetics, Seroquel IR, Merrem, Diprivan and other Products			USD	Millions	1,152	1,500	1,152	1,500	-348	-23
170	AstraZeneca	Total Other			USD	Millions	5,067	6,340	5,067	6,340	-1,273	-20
171	AstraZeneca	Total Pharmaceuticals			USD	Millions	21,319	23,641	21,319	23,641	-2,322	-10
172	AstraZeneca	Total Externalisation Revenue			USD	Millions	1,683	1,067	1,683	1,067	616	58
173	AstraZeneca	Total Pharmaceuticals			USD	Millions	23,002	24,708	23,002	24,708	-1,706	-7
174	Baxter			Renal	USD	Millions	3,855	3,789	3,855	3,789	66	2
175	Baxter			Hospital Products	USD	Millions	6,308	6,179	6,308	6,179	129	2
176	Baxter	Total Revenue			USD	Millions	10,163	9,968	10,163	9,968	195	2
177	Bayer	Xarelto	Rivaroxaban	Cardiovascular Diseases	Euro	Millions	2,928	2,252	3,104	2,387	717	30
178	Bayer	Kogenate	Antihemophilic Factor (Recombinant)	Rare Diseases	Euro	Millions	1,166	1,155	1,236	1,224	12	1
179	Bayer	Betaferon/Betaseron	Interferon Beta-1B	Neurological/Mental Disorders	Euro	Millions	734	824	778	873	-95	-11
180	Bayer	Mirena Product Family	Levonorgestrel	Sexual Health	Euro	Millions	1,043	968	1,106	1,026	80	8
181	Bayer	Nexavar	Sorafenib	Oncology	Euro	Millions	870	892	922	946	-23	-2
182	Bayer	Yaz/Yasim/Yasminelle	Drospirenone And Ethinyl Estradiol	Sexual Health	Euro	Millions	678	706	719	748	-30	-4
183	Bayer	Eylea	Aflibercept	Ophthalmology	Euro	Millions	1,625	1,228	1,723	1,302	421	32
184	Bayer	Adalat	Nifedipine	Cardiovascular Diseases	Euro	Millions	624	633	661	671	-10	-1
185	Bayer	Aspirin Cardio	Acetylsalicylic Acid	Cardiovascular Diseases	Euro	Millions	538	524	570	555	15	3
186	Bayer	Xofigo	Radium Ra 223 Dichloride	Oncology	Euro	Millions	331	257	351	272	78	29
187	Bayer	Glucobay	Acarbose	Diabetes	Euro	Millions	515	523	546	554	-8	-2
188	Bayer	Avalox/Avelox	Moxifloxacin Hydrochloride	Anti-Bacterial	Euro	Millions	353	379	374	402	-28	-7
189	Bayer	Stivarga	Regorafenib	Oncology	Euro	Millions	275	313	292	332	-40	-12
190	Bayer	Gadavist/Gadovist	Ezetimibe	Cardiovascular Diseases	Euro	Millions	346	290	367	307	59	19
191	Bayer	Ultravist	Iopromide	Iodinated Contrast Agent	Euro	Millions	316	318	335	337	-2	-1
192	Bayer	Total Pharmaceuticals			Euro	Millions	16,420	15,308	17,405	16,226	1,179	7
193	Bayer			Consumer Health	Euro	Millions	6,037	6,076	6,399	6,441	-41	-1
194	Bayer			Crop Science	Euro	Millions	9,915	10,128	10,510	10,736	-226	-2
195	Bayer			Animal Health	Euro	Millions	1,523	1,490	1,614	1,579	35	2
196	Bayer	Total Life Science (Incl. Reconciliation)			Euro	Millions	34,943	34,103	37,040	36,149	890	2
197	Bayer	Covestro			Euro	Millions	11,826	11,982	12,536	12,701	-165	-1
198	Bayer	Total Group Sales			Euro	Millions	46,769	46,085	49,575	48,850	725	1
199	Biogen	Tecfidera	Dimethyl Fumarate	Neurological/Mental Disorders	USD	Millions	3,968	3,638	3,968	3,638	330	9
200	Biogen	Avonex	Interferon Beta-1A	Neurological/Mental Disorders	USD	Millions	2,314	2,630	2,314	2,630	-316	-12
201	Biogen	Plegridy	Peginterferon Beta-1A	Neurological/Mental Disorders	USD	Millions	482	339	482	339	143	42
202	Biogen	Tysabri	Natalizumab	Neurological/Mental Disorders	USD	Millions	1,964	1,886	1,964	1,886	78	4
203	Biogen	Fampyra	Fampridine	Neurological/Mental Disorders	USD	Millions	85	90	85	90	-5	-6
204	Biogen	Zinbryta	Daclizumab	Neurological/Mental Disorders	USD	Millions	8	Not Reported	8	Not Reported	8	New Launch
205	Biogen	Total Multiple Sclerosis			USD	Millions	8,820	8,583	8,820	8,583	237	3
206	Biogen	Eloctate	Antihemophilic Factor (Recombinant), Fc Fusion Protein	Blood Disorders	USD	Millions	513	320	513	320	193	60
207	Biogen	Alprolix	Coagulation Factor Ix (Recombinant), Fc Fusion Protein	Blood Disorders	USD	Millions	334	235	334	235	99	42
208	Biogen	Total Hemophilia			USD	Millions	847	554	847	554	293	53
209	Biogen	Spinraza	Nusinersen	Spinal Muscular Atrophy	USD	Millions	5	Not Reported	5	Not Reported	5	New Launch
210	Biogen	Benepali	Etanercept	Immunology (Organ Transplant, Arthritis etc.)	USD	Millions	101	Not Reported	101	Not Reported	101	New Launch
211	Biogen	Flixabi	Infliximab	Immunology (Organ Transplant, Arthritis etc.)	USD	Millions	0.1	Not Reported	0.1	Not Reported	0	New Launch
212	Biogen	Fumaderm	Fumapharm Ag	Anti-Fungal	USD	Millions	46	51	46	51	-5	-10
213	Biogen	Total Other Product Revenues			USD	Millions	151	51	151	51	100	196
214	Biogen	Total Product Revenues			USD	Millions	9,818	9,189	9,818	9,189	629	7
215	Biogen	Anti-Cd20 Revenues			USD	Millions	1,315	1,339	1,315	1,339	-24	-2
216	Biogen	Other Revenues			USD	Millions	316	236	316	236	80	34
217	Biogen	Total Sales			USD	Millions	11,449	10,764	11,449	10,764	685	6
218	Boehringer Ingelheim	Spiriva	Tiotropium Bromide	Respiratory Disorders	Euro	Millions	2,995	3,553	3,175	3,766	-591	-16
219	Boehringer Ingelheim	Pradaxa	Dabigatran Etexilate	Blood Disorders	Euro	Millions	1,385	1,287	1,468	1,364	104	8
220	Boehringer Ingelheim	Micardis	Telmisartan	Cardiovascular Diseases	Euro	Millions	959	956	1,017	1,013	3	0
221	Boehringer Ingelheim	Trajenta/Jentadueto	Linagliptin	Diabetes	Euro	Millions	1,128	909	1,196	964	232	24
222	Boehringer Ingelheim	Prescription Medicines			Euro	Millions	12,036	11,201	12,758	11,873	885	7
223	Boehringer Ingelheim	Dulcolax	Sodium Picosulphate	Gastrointestinal Disorders	Euro	Millions	237	225	251	239	13	5
224	Boehringer Ingelheim	Buscopan	Hyoscine Butylbromide	Anti-Inflammatory	Euro	Millions	236	223	250	236	14	6
225	Boehringer Ingelheim	Mucosolvan	Ambroxol	Respiratory Disorders	Euro	Millions	136	168	144	178	-34	-19
226	Boehringer Ingelheim	Pharmaton	Multivitamins	Dietary Supplement	Euro	Millions	145	140	154	148	5	4
227	Boehringer Ingelheim	Consumer Healthcare			Euro	Millions	1,578	1,513	1,673	1,604	69	4
228	Boehringer Ingelheim	Ingelvac Circo?ex	PCV2 Vaccine	Vaccines	Euro	Millions	283	281	300	298	2	1
229	Boehringer Ingelheim	Metacam	Meloxicam	Anti-Inflammatory	Euro	Millions	106	101	112	107	5	5
230	Boehringer Ingelheim	Ingelvac Prrs	Modified-Live Prrs Vaccine	Vaccines	Euro	Millions	114	99	121	105	16	15
231	Boehringer Ingelheim	Duramune	Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine	Vaccines	Euro	Millions	100	88	106	93	13	14
232	Boehringer Ingelheim	Animal Health			Euro	Millions	1,460	1,363	1,548	1,445	103	7
233	Boehringer Ingelheim	Biopharmaceuticals			Euro	Millions	613	576	650	611	39	6
234	Boehringer Ingelheim	Industrial Customers And Other Sales			Euro	Millions	163	145	173	154	19	12
235	Boehringer Ingelheim	Total Sales			Euro	Millions	15,850	14,798	16,801	15,686	1,115	7
236	Bristol Myers Squibb	Baraclude	Entecavir	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	1,192	1,312	1,192	1,312	-120	-9
237	Bristol Myers Squibb	Hepatits C Franchise	Daclatasvir And Asunaprevir	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	1,578	1,603	1,578	1,603	-25	-2
238	Bristol Myers Squibb	Reyataz	Atazanavir Sulphate	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	912	1,139	912	1,139	-227	-20
239	Bristol Myers Squibb	Sustiva	Efavirenz	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	1,065	1,252	1,065	1,252	-187	-15
240	Bristol Myers Squibb	Total Virology			USD	Millions	4,747	5,306	4,747	5,306	-559	-11
241	Bristol Myers Squibb	Empliciti	Elotuzumab	Oncology	USD	Millions	150	3	150	3	147	4,900
242	Bristol Myers Squibb	Erbitux	Cetuximab	Oncology	USD	Millions	Not Reported	501	Not Reported	501	-501	-100
243	Bristol Myers Squibb	Opdivo	Nivolumab	Oncology	USD	Millions	3,774	942	3,774	942	2,832	301
244	Bristol Myers Squibb	Sprycel	Dasatinib	Oncology	USD	Millions	1,824	1,620	1,824	1,620	204	13
245	Bristol Myers Squibb	Yervoy	Ipilimumab	Oncology	USD	Millions	1,053	1,126	1,053	1,126	-73	-6
246	Bristol Myers Squibb	Total Oncology			USD	Millions	6,801	4,192	6,801	4,192	2,609	62
247	Bristol Myers Squibb	Abilify	Aripiprazole	Neurological/Mental Disorders	USD	Millions	128	746	128	746	-618	-83
248	Bristol Myers Squibb	Total Neuroscience			USD	Millions	128	746	128	746	-618	-83
249	Bristol Myers Squibb	Orencia	Abatacept	Immunology (Organ Transplant, Arthritis etc.)	USD	Millions	2,265	1,885	2,265	1,885	380	20
250	Bristol Myers Squibb	Total Immunoscience			USD	Millions	2,265	1,885	2,265	1,885	380	20
251	Bristol Myers Squibb	Eliquis	Apixaban	Blood Disorders	USD	Millions	3,343	1,860	3,343	1,860	1,483	80
252	Bristol Myers Squibb	Total Cardiovascular			USD	Millions	3,343	1,860	3,343	1,860	1,483	80
253	Bristol Myers Squibb	Total Other Mature Products			USD	Millions	2,143	2,571	2,143	2,571	-428	-17
254	Bristol Myers Squibb	Total Excluding Diabetes Alliance			USD	Millions	Not Reported	16,364	Not Reported	16,364	-16,364	-100
255	Bristol Myers Squibb	Total Pharmaceuticals			USD	Millions	19,427	16,560	19,427	16,560	2,867	17
256	Celgene	Revlimid	Lenalidomide	Oncology	USD	Millions	6,974	5,801	6,974	5,801	1,173	20
257	Celgene	Abraxane	Paclitaxel Protein-Bound	Oncology	USD	Millions	973	968	973	968	5	1
258	Celgene	Pomalyst/Imnovid	Pomalidomide	Oncology	USD	Millions	1,311	983	1,311	983	328	33
259	Celgene	Otezla	Apremilast	Dermatology	USD	Millions	1,017	472	1,017	472	545	115
260	Celgene	Vidaza	Azacitidine	Oncology	USD	Millions	608	591	608	591	17	3
261	Celgene	Azacitidine For Injection	Azacitidine	Oncology	USD	Millions	66	84	66	84	-18	-21
262	Celgene	Thalomid	Thalidomide	Oncology	USD	Millions	152	185	152	185	-33	-18
263	Celgene	Istodax	Romidepsin	Oncology	USD	Millions	79	69	79	69	10	14
264	Celgene	Others			USD	Millions	4	8	4	8	-4	-50
265	Celgene	Total Net Product Sales			USD	Millions	11,185	9,161	11,185	9,161	2,024	22
266	Celgene	Other Revenues			USD	Millions	45	95	45	95	-50	-53
267	Celgene	Total Revenues			USD	Millions	11,229	9,256	11,229	9,256	1,973	21
268	Chugai			Oncology	Yen	Millions	220,300	215,700	1,983	1,941	41	2
269	Chugai			Bone And Joint Diseases	Yen	Millions	86,100	79,400	775	715	60	8
270	Chugai			Renal Disorders	Yen	Millions	41,100	45,400	370	409	-39	-9
271	Chugai			Immunology (Organ Transplant, Arthritis etc.)	Yen	Millions	13,700	15,900	123	143	-20	-14
272	Chugai	Others			Yen	Millions	18,500	21,700	167	195	-29	-15
273	Chugai	Overseas			Yen	Millions	79,500	82,200	716	740	-24	-3
274	Chugai	Domestic Sales (Excluding Tamiflu)			Yen	Millions	379,700	378,000	3,417	3,402	15	0
275	Chugai	Tamiflu Sales	Oseltamivir Phosphate	Anti-Viral	Yen	Millions	13,500	8,200	122	74	48	65
276	Chugai	Total Sales			Yen	Millions	472,700	468,400	4,254	4,216	39	1
277	Chugai	Royalties And Other Operating Income			Yen	Millions	19,100	30,400	172	274	-102	-37
278	Chugai	Total Revenues			Yen	Millions	491,800	498,800	4,426	4,489	-63	-1
279	Dainippon Sumitomo	Surepost	Repaglinide	Diabetes	Yen	Millions	4,200	3,400	38	31	7	24
280	Dainippon Sumitomo	Ambisome	Amphotericin B	Anti-fungal	Yen	Millions	4,500	4,200	41	38	3	7
281	Dainippon Sumitomo	Lunesta	Eszopiclone	Sleep Disorders	Yen	Millions	200	5,500	2	50	-48	-96
282	Dainippon Sumitomo	Xopenex	Levalbuterol	Respiratory Disorders	Yen	Millions	5,600	6,800	50	61	-11	-18
283	Dainippon Sumitomo	Ciclesonide	Ciclesonide	Respiratory Disorders	Yen	Millions	5,300	6,900	48	62	-14	-23
284	Dainippon Sumitomo	Aptiom	Eslicarbazepine	Neurological/Mental Disorders	Yen	Millions	10,200	6,300	92	57	35	62
285	Dainippon Sumitomo	Replagal	Agalsidase alfa	Renal Disorders	Yen	Millions	10,600	10,100	95	91	5	5
286	Dainippon Sumitomo	Avapro	Irbesartan	Cardiovascular Diseases	Yen	Millions	10,500	11,100	95	100	-5	-5
287	Dainippon Sumitomo	Lonasen	Blonanserin	Neurological/Mental Disorders	Yen	Millions	12,900	12,800	116	115	1	1
288	Dainippon Sumitomo	Trerief/Excegran	Zonisamide	Neurological/Mental Disorders	Yen	Millions	14,700	13,300	132	120	13	11
289	Dainippon Sumitomo	Metgluco	Biguanide	Diabetes	Yen	Millions	11,400	16,300	103	147	-44	-30
290	Dainippon Sumitomo	Aimix	Amlodipine, Irbesartan	Cardiovascular Diseases	Yen	Millions	16,100	14,800	145	133	12	9
291	Dainippon Sumitomo	Amlodin	Amlodipine	Cardiovascular Diseases	Yen	Millions	13,700	17,500	123	158	-34	-22
292	Dainippon Sumitomo	Brovana	Arformoterol	Respiratory Disorders	Yen	Millions	32,500	28,800	293	259	33	13
293	Dainippon Sumitomo	Latuda	Lurasidone	Neurological/Mental Disorders	Yen	Millions	128,700	112,000	1,158	1,008	150	15
294	Dainippon Sumitomo	Meropen	Meropenem Hydrate	Anti-bacterial	Yen	Millions	27,200	28,400	245	256	-11	-4
295	Dainippon Sumitomo	Gasmotin	Mosapride Citrate	Gastrointestinal Disorders	Yen	Millions	6,500	9,100	59	82	-23	-29
296	Dainippon Sumitomo	Prorenal	limaprost alfadex	Neurological/Mental Disorders	Yen	Millions	7,000	9,300	63	84	-21	-25
297	Dainippon Sumitomo	Ebastel	Ebastine	Anti-Allergic	Yen	Millions	1,000	3,400	9	31	-22	-71
298	Dainippon Sumitomo	Total Sales			Yen	Millions	404,200	396,770	3,638	3,571	67	2
299	Eli Lilly	Zyprexa	Olanzapine	Neurological/Mental Disorders	USD	Millions	725	940	725	940	-215	-23
300	Eli Lilly	Cymbalta	Duloxetine	Neurological/Mental Disorders	USD	Millions	931	1,028	931	1,028	-97	-9
301	Eli Lilly	Strattera	Atomoxetine	Neurological/Mental Disorders	USD	Millions	855	784	855	784	71	9
302	Eli Lilly	Prozac	Fluoxetine	Neurological/Mental Disorders	USD	Millions	182	155	182	155	27	17
303	Eli Lilly	Amyvid	Florbetapir	Neurological/Mental Disorders	USD	Millions	Not Reported	6	Not Reported	6	-6	-100
304	Eli Lilly	Other Neuroscience			USD	Millions	28	23	28	23	5	22
305	Eli Lilly	Total Neuroscience			USD	Millions	2,720	2,935	2,720	2,935	-215	-7
306	Eli Lilly	Taltz	Ixekizumab	Dermatology	USD	Millions	113	Not Reported	113	Not Reported	113	New Launch
307	Eli Lilly	Total Immunology			USD	Millions	113	Not Reported	113	Not Reported	113	Not Reported
308	Eli Lilly	Humalog	Insulin Lispro	Diabetes	USD	Millions	2,769	2,842	2,769	2,842	-73	-3
309	Eli Lilly	Humulin	Insulin Isophane	Diabetes	USD	Millions	1,366	1,307	1,366	1,307	59	5
310	Eli Lilly	Evista	Raloxifene	Bone Health	USD	Millions	173	237	173	237	-64	-27
311	Eli Lilly	Forteo	Teriparatide	Bone Health	USD	Millions	1,500	1,348	1,500	1,348	152	11
312	Eli Lilly	Humatrope	Somatropin	Hormonal Disorders	USD	Millions	304	312	304	312	-8	-3
313	Eli Lilly	Axiron	Testosterone	Hormonal Disorders	USD	Millions	145	155	145	155	-10	-6
314	Eli Lilly	Glucagon	Rdna Origin	Diabetes	USD	Millions	133	121	133	121	12	10
315	Eli Lilly	Trajenta	Linagliptin	Diabetes	USD	Millions	437	357	437	357	80	22
316	Eli Lilly	Jardiance	Empagliflozin	Diabetes	USD	Millions	202	60	202	60	142	237
317	Eli Lilly	Trulicity	Dulaglutide	Diabetes	USD	Millions	926	249	926	249	677	272
318	Eli Lilly	Basaglar	Insulin Glargine	Diabetes	USD	Millions	86	11	86	11	75	682
319	Eli Lilly	Other Endocrinology			USD	Millions	43	37	43	37	6	16
320	Eli Lilly	Total Endocrinology			USD	Millions	8,083	7,037	8,083	7,037	1,046	15
321	Eli Lilly	Alimta	Pemetrexed	Oncology	USD	Millions	2,283	2,493	2,283	2,493	-210	-8
322	Eli Lilly	Gemzar	Gemcitabine	Oncology	USD	Millions	111	147	111	147	-36	-24
323	Eli Lilly	Cyramza	Ramucirumab	Oncology	USD	Millions	614	384	614	384	230	60
324	Eli Lilly	Portrazza	Necitumumab	Oncology	USD	Millions	15	Not Reported	15	Not Reported	15	New Launch
325	Eli Lilly	Lartruvo	Olaratumab	Oncology	USD	Millions	12	Not Reported	12	Not Reported	12	New Launch
326	Eli Lilly	Erbitux	Cetuximab	Oncology	USD	Millions	687	485	687	485	202	42
327	Eli Lilly	Other Oncology			USD	Millions	-0.2	1	-0.2	1	-1	-120
328	Eli Lilly	Total Oncology			USD	Millions	3,722	3,510	3,722	3,510	212	6
329	Eli Lilly	Cialis	Tadalafil	Sexual Health	USD	Millions	2,472	2,311	2,472	2,311	161	7
330	Eli Lilly	Reopro	Abciximab	Cardiovascular Diseases	USD	Millions	87	98	87	98	-11	-11
331	Eli Lilly	Effient	Prasugrel	Cardiovascular Diseases	USD	Millions	535	523	535	523	12	2
332	Eli Lilly	Adcirca	Tadalafil	Cardiovascular Diseases	USD	Millions	82	76	82	76	6	8
333	Eli Lilly	Other Cardiovascular			USD	Millions	51	61	51	61	-10	-16
334	Eli Lilly	Total Cardiovascular			USD	Millions	3,225	3,068	3,225	3,068	157	5
335	Eli Lilly	Vancocin	Vancomycin Hydrochloride	Anti-Bacterial	USD	Millions	85	90	85	90	-5	-6
336	Eli Lilly	Others			USD	Millions	116	138	116	138	-22	-16
337	Eli Lilly	Other Pharmaceutical			USD	Millions	201	228	201	228	-27	-12
338	Eli Lilly	Total Pharmaceuticals			USD	Millions	18,064	16,778	18,064	16,778	1,286	8
339	Eli Lilly	Food And Other			USD	Millions	2,189	2,262	2,189	2,262	-73	-3
340	Eli Lilly	Companion			USD	Millions	970	919	970	919	51	6
341	Eli Lilly	Total Animal Health			USD	Millions	3,158	3,181	3,158	3,181	-23	-1
342	Eli Lilly	Total Revenues			USD	Millions	21,222	19,959	21,223	19,959	1,264	6
343	Fresenius Kabi	Fresenius Medical Care			USD	Millions	16,181	15,086	16,181	15,086	1,095	7
344	Fresenius Kabi	Fresenius Kabi			USD	Millions	6,007	5,950	6,007	5,950	57	1
345	Fresenius Kabi	Fresenius Helios			USD	Millions	5,843	5,578	5,843	5,578	265	5
346	Fresenius Kabi	Fresenius Vamed			USD	Millions	1,160	1,118	1,160	1,118	42	4
347	Fresenius Kabi	Total Revenues			USD	Millions	29,083	27,626	29,083	27,626	1,457	5
348	Gilead	Sovaldi	Sofosbuvir	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	4,001	5,276	4,001	5,276	-1,275	-24
349	Gilead	Atripla	Efavirenz, Emtricitabine, And Tenofovir Disoproxil Fumarate	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	2,605	3,134	2,605	3,134	-529	-17
350	Gilead	Truvada	Emtricitabine, And Tenofovir Disoproxil Fumarate	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	3,566	3,459	3,566	3,459	107	3
351	Gilead	Harvoni	Ledipasvir And Sofosbuvir	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	9,081	13,864	9,081	13,864	-4,783	-34
352	Gilead	Complera/Eviplera	Rilpivirine, Emtricitabine, And Tenofovir Disoproxil Fumarate	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	1,457	1,427	1,457	1,427	30	2
353	Gilead	Stribild	Cobicistat, Elvitegravir, Emtricitabine And Tenofovir Disoproxil Fumarate	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	1,914	1,825	1,914	1,825	89	5
354	Gilead	Viread	Tenofovir Disoproxil Fumarate	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	1,186	1,108	1,186	1,108	78	7
355	Gilead	Epclusa	Sofosbuvir And Velpatasvir	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	1,752	Not Reported	1,752	Not Reported	1,752	New Launch
356	Gilead	Odefsey	Emtricitabine, Rilpivirine, And Tenofovir Alafenamide	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	329	Not Reported	329	Not Reported	329	New Launch
357	Gilead	Descovy	Emtricitabine And Tenofovir Alafenamide	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	298	Not Reported	298	Not Reported	298	New Launch
358	Gilead	Genvoya	Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	1,484	45	1,484	45	1,439	3,198
359	Gilead	Other Antiviral			USD	Millions	72	69	72	69	3	4
360	Gilead	Total Antiviral Products			USD	Millions	27,745	30,207	27,745	30,207	-2,462	-8
361	Gilead	Letairis	Ambrisentan	Cardiovascular Diseases	USD	Millions	819	700	819	700	119	17
362	Gilead	Ranexa	Ranolazine	Cardiovascular Diseases	USD	Millions	677	588	677	588	89	15
363	Gilead	Ambisome	Amphotericin B	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	356	350	356	350	6	2
364	Gilead	Zydelig	Idelalisib	Oncology	USD	Millions	168	132	168	132	36	27
365	Gilead	Others			USD	Millions	188	174	188	174	14	8
366	Gilead	Total Other Products			USD	Millions	2,208	1,944	2,208	1,944	264	14
367	Gilead	Total Product Sales			USD	Millions	29,953	32,151	29,953	32,151	-2,198	-7
368	Gilead	Royalty Contract And Other Revenues			USD	Millions	437	488	437	488	-51	-10
369	Gilead	Total Revenues			USD	Millions	30,390	32,639	30,390	32,639	-2,249	-7
370	GlaxoSmithKline Plc	Anoro Ellipta	Umeclidinium And Vilanterol	Respiratory Disorders	GBP	Millions	201	79	249	98	151	154
371	GlaxoSmithKline Plc	Avamys/Veramyst	Fluticasone Furoate	Respiratory Disorders	GBP	Millions	277	229	343	284	60	21
372	GlaxoSmithKline Plc	Flixotide/Flovent	Fluticasone Propionate	Respiratory Disorders	GBP	Millions	637	623	790	773	17	2
373	GlaxoSmithKline Plc	Relvar/Breo Ellipta	Fluticasone Furoate	Respiratory Disorders	GBP	Millions	620	257	769	319	450	141
374	GlaxoSmithKline Plc	Seretide/Advair	Salmeterol	Respiratory Disorders	GBP	Millions	3,485	3,681	4,321	4,564	-243	-5
375	GlaxoSmithKline Plc	Incruse Ellipta	Umeclidinium	Respiratory Disorders	GBP	Millions	114	14	141	17	124	729
376	GlaxoSmithKline Plc	Nucala	Mepolizumab	Respiratory Disorders	GBP	Millions	102	1	126	2	124	6,200
377	GlaxoSmithKline Plc	Arnuity Ellipta	Fluticasone Furoate	Respiratory Disorders	GBP	Millions	15	3	19	4	15	375
378	GlaxoSmithKline Plc	Ventolin	Albuterol	Respiratory Disorders	GBP	Millions	785	620	973	769	205	27
379	GlaxoSmithKline Plc	Others			GBP	Millions	274	252	340	312	27	9
380	GlaxoSmithKline Plc	Total Respiratory			GBP	Millions	6,510	5,741	8,072	7,119	954	13
381	GlaxoSmithKline Plc	Avodart	Dutasteride	Urology	GBP	Millions	635	657	787	815	-27	-3
382	GlaxoSmithKline Plc	Eperzan/Tanzeum	Albiglutide	Diabetes	GBP	Millions	121	41	150	50	100	200
383	GlaxoSmithKline Plc	Other			GBP	Millions	104	201	129	249	-120	-48
384	GlaxoSmithKline Plc	Total Cardiovascular, Metabolic And Urology			GBP	Millions	860	858	1,066	1,064	2	0
385	GlaxoSmithKline Plc	Benlysta	Belimumab	Rare Diseases	GBP	Millions	306	230	379	285	94	33
386	GlaxoSmithKline Plc	Others			GBP	Millions	34	33	42	41	1	3
387	GlaxoSmithKline Plc	Total Immuno-Inflammation			GBP	Millions	340	263	422	326	95	29
388	GlaxoSmithKline Plc	Dermatology			GBP	Millions	393	412	487	511	-24	-5
389	GlaxoSmithKline Plc	Augmentin	Amoxicillin And Clavulanate Potassium	Anti-Bacterial	GBP	Millions	563	528	698	655	43	7
390	GlaxoSmithKline Plc	Other Anti-Bacterials			GBP	Millions	169	184	210	228	-19	-8
391	GlaxoSmithKline Plc	Rare Diseases			GBP	Millions	423	371	525	460	64	14
392	GlaxoSmithKline Plc	Oncology			GBP	Millions	161	255	200	316	-117	-37
393	GlaxoSmithKline Plc	Others			GBP	Millions	588	704	729	873	-144	-16
394	GlaxoSmithKline Plc	Total Other Pharmaceuticals			GBP	Millions	2,297	2,445	2,848	3,043	-195	-6
395	GlaxoSmithKline Plc	Bexsero	Meningococcal vaccine	Vaccines	GBP	Millions	390	115	484	143	341	239
396	GlaxoSmithKline Plc	Boostrix	Diphtheria, Tetanus Acellular, and Pertussis	Vaccines	GBP	Millions	470	358	583	444	139	31
397	GlaxoSmithKline Plc	Cervarix	Human Papillomavirus Bivalent	Vaccines	GBP	Millions	81	88	100	109	-9	-8
398	GlaxoSmithKline Plc	Fluarix, Flulaval	Influenza vaccine	Vaccines	GBP	Millions	414	268	513	332	181	54
399	GlaxoSmithKline Plc	Hepatitis	Vaccine	Vaccines	GBP	Millions	602	540	746	670	77	11
400	GlaxoSmithKline Plc	Infanrix, Pediarix	Diphtheria, Tetanus Acellular, and Pertussis	Vaccines	GBP	Millions	769	733	954	909	45	5
401	GlaxoSmithKline Plc	Menveo	Meningococcal vaccine	Vaccines	GBP	Millions	202	160	250	198	52	26
402	GlaxoSmithKline Plc	Rabipur/Rabivert	Vaccine	Vaccines	GBP	Millions	Not Reported	61	Not Reported	76	-76	-100
403	GlaxoSmithKline Plc	Rotarix	Vaccine	Vaccines	GBP	Millions	469	417	582	517	64	12
404	GlaxoSmithKline Plc	Priorix, Priorix Tetra, Varilrix	Vaccine	Vaccines	GBP	Millions	300	260	372	320	52	16
405	GlaxoSmithKline Plc	Synflorix	Vaccine	Vaccines	GBP	Millions	504	381	625	472	153	32
406	GlaxoSmithKline Plc	Others			GBP	Millions	391	536	485	665	-180	-27
407	GlaxoSmithKline Plc	Total Vaccines			GBP	Millions	4,592	3,656	5,694	4,535	1,159	26
408	GlaxoSmithKline Plc	Combivir	Lamivudine And Zidovudine	Infectious Diseases (HIV, Hepatitis etc.)	GBP	Millions	23	34	29	42	-14	-32
409	GlaxoSmithKline Plc	Epzicom/Kivexa	Abacavir And Lamivudine	Infectious Diseases (HIV, Hepatitis etc.)	GBP	Millions	568	698	704	866	-161	-19
410	GlaxoSmithKline Plc	Lexiva/Agenerase	Fosamprenavir	Infectious Diseases (HIV, Hepatitis etc.)	GBP	Millions	51	65	63	81	-17	-22
411	GlaxoSmithKline Plc	Selzentry	Maraviroc	Infectious Diseases (HIV, Hepatitis etc.)	GBP	Millions	125	124	155	154	1	1
412	GlaxoSmithKline Plc	Tivicay	Dolutegravir	Infectious Diseases (HIV, Hepatitis etc.)	GBP	Millions	953	588	1,182	729	453	62
413	GlaxoSmithKline Plc	Triumeq	Abacavir, Dolutegravir And Lamivudine	Infectious Diseases (HIV, Hepatitis etc.)	GBP	Millions	1,735	730	2,151	905	1,246	138
414	GlaxoSmithKline Plc	Trizivir	Abacavir, Lamivudine, And Zidovudine	Infectious Diseases (HIV, Hepatitis etc.)	GBP	Millions	16	26	20	32	-12	-38
415	GlaxoSmithKline Plc	Others			GBP	Millions	85	57	105	71	35	49
416	GlaxoSmithKline Plc	Total HIV			GBP	Millions	3,556	2,322	4,409	2,879	1,530	53
417	GlaxoSmithKline Plc	Coreg	Carvedilol	Cardiovascular Diseases	GBP	Millions	131	123	162	153	10	7
418	GlaxoSmithKline Plc	Hepsera	Adefovir	Infectious Diseases (HIV, Hepatitis etc.)	GBP	Millions	58	63	72	78	-6	-8
419	GlaxoSmithKline Plc	Imigran/Imitrex	Sumatriptan Succinate	Neurological/Mental Disorders	GBP	Millions	177	160	219	198	21	11
420	GlaxoSmithKline Plc	Lamictal	Lamotrigine	Neurological/Mental Disorders	GBP	Millions	614	531	761	658	103	16
421	GlaxoSmithKline Plc	Lovaza	Omega-3 Polyunsaturated Fatty Acids	Cardiovascular Diseases	GBP	Millions	43	93	53	115	-62	-54
422	GlaxoSmithKline Plc	Requip	Ropinirole	Neurological/Mental Disorders	GBP	Millions	116	93	144	115	29	25
423	GlaxoSmithKline Plc	Serevent	Salmeterol	Respiratory Disorders	GBP	Millions	96	93	119	115	4	3
424	GlaxoSmithKline Plc	Seroxat/ Paxil	Paroxetine Hydrochloride Hemihydrate	Neurological/Mental Disorders	GBP	Millions	206	165	255	205	51	25
425	GlaxoSmithKline Plc	Valtrex	Valacyclovir	Infectious Diseases (HIV, Hepatitis etc.)	GBP	Millions	118	165	146	205	-58	-28
426	GlaxoSmithKline Plc	Zeffix	Lamivudine	Infectious Diseases (HIV, Hepatitis etc.)	GBP	Millions	111	134	138	166	-29	-17
427	GlaxoSmithKline Plc	Others			GBP	Millions	871	908	1,080	1,126	-46	-4
428	GlaxoSmithKline Plc	Established Products			GBP	Millions	2,541	2,528	3,151	3,135	16	1
429	GlaxoSmithKline Plc	Total Pharmaceuticals			GBP	Millions	16,104	14,157	19,969	17,566	2,403	14
430	GlaxoSmithKline Plc	Consumer Healthcare Turnover			GBP	Millions	7,193	6,038	8,919	7,475	1,445	19
431	GlaxoSmithKline Plc	Total Sales			GBP	Millions	27,889	23,923	34,582	29,575	5,007	17
432	Ipsen	Decapeptyl	Triptorelin	Hormonal Disorders	Euro	Millions	340	334	360	354	6	2
433	Ipsen	Somatuline	Lanreotide	Oncology	Euro	Millions	538	402	570	426	144	34
434	Ipsen	Cabometyx	Cabozantinib	Oncology	Euro	Millions	7	Not Reported	7	Not Reported	7	New Launch
435	Ipsen	Other Oncology			Euro	Millions	20	17	21	18	3	18
436	Ipsen	Oncology			Euro	Millions	905	753	959	798	161	20
437	Ipsen	Dysport	Abobotulinumtoxin A	Lower Limb Spasticity	Euro	Millions	285	280	302	297	5	2
438	Ipsen	Neuroscience			Euro	Millions	285	280	302	297	5	2
439	Ipsen	Nutropin	Somatropin (Rdna Origin)	Hormonal Disorders	Euro	Millions	58	60	61	64	-2	-3
440	Ipsen	Increlex	Mecasermin	Metabolic Disorders	Euro	Millions	24	20	25	21	4	20
441	Ipsen	Endocrinology			Euro	Millions	81	80	86	85	1	1
442	Ipsen	Total Specialty Care			Euro	Millions	1,273	1,114	1,349	1,181	169	14
443	Ipsen	Smecta	Dioctahedral Smectite	Gastrointestinal Disorders	Euro	Millions	111	115	118	122	-4	-3
444	Ipsen	Fortrans	Macrogol	Gastrointestinal Disorders	Euro	Millions	23	24	24	25	-1	-4
445	Ipsen	Etiasa	Mesalazine	Gastrointestinal Disorders	Euro	Millions	29	26	31	28	3	12
446	Ipsen	Forlax	Macrogol	Gastrointestinal Disorders	Euro	Millions	39	40	41	42	-1	-3
447	Ipsen	Gastroenterology			Euro	Millions	219	227	232	241	-8	-4
448	Ipsen	Tanakan	Ginkgo Biloba Extract	Neurological/Mental Disorders	Euro	Millions	44	52	47	55	-8	-15
449	Ipsen	Cognitive Disorders			Euro	Millions	44	52	47	55	-8	-15
450	Ipsen	Other Primary Care			Euro	Millions	24	26	25	28	-2	-8
451	Ipsen	Drug-Related Sales			Euro	Millions	26	24	28	25	2	8
452	Ipsen	Total Primary Care			Euro	Millions	312	330	331	350	-19	-5
453	Ipsen	Total Sales			Euro	Millions	1,585	1,444	1,680	1,531	149	10
454	Johnson & Johnson	Remicade	Infliximab	Immunology (Organ Transplant, Arthritis etc.)	USD	Millions	6,966	6,561	6,966	6,561	405	6
455	Johnson & Johnson	Simponi/Simponi Aria	Golimumab	Immunology (Organ Transplant, Arthritis etc.)	USD	Millions	1,745	1,328	1,745	1,328	417	31
456	Johnson & Johnson	Stelara	Ustekinumab	Immunology (Organ Transplant, Arthritis etc.)	USD	Millions	3,232	2,474	3,232	2,474	758	31
457	Johnson & Johnson	Other Products			USD	Millions	25	39	25	39	-14	-36
458	Johnson & Johnson	Total Immunology			USD	Millions	11,968	10,402	11,968	10,402	1,566	15
459	Johnson & Johnson	Edurant	Rilpivirine	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	573	410	573	410	163	40
460	Johnson & Johnson	Olysio/Sovriad	Simeprevir	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	106	621	106	621	-515	-83
461	Johnson & Johnson	Prezista	Darunavir	Infectious Diseases (HIV, Hepatitis etc.)	USD	Millions	1,851	1,810	1,851	1,810	41	2
462	Johnson & Johnson	Other Products			USD	Millions	678	815	678	815	-137	-17
463	Johnson & Johnson	Total Infectious Diseases			USD	Millions	3,208	3,656	3,208	3,656	-448	-12
464	Johnson & Johnson	Concerta	Methylphenidate	Neurological/Mental Disorders	USD	Millions	863	821	863	821	42	5
465	Johnson & Johnson	Invega	Paliperidone	Neurological/Mental Disorders	USD	Millions	311	573	311	573	-262	-46
466	Johnson & Johnson	Invega Sustenna/Xeplion	Paliperidone Palmitate	Neurological/Mental Disorders	USD	Millions	2,214	1,830	2,214	1,830	384	21
467	Johnson & Johnson	Risperdal Consta	Risperidone	Neurological/Mental Disorders	USD	Millions	893	970	893	970	-77	-8
468	Johnson & Johnson	Other Products			USD	Millions	1,804	2,065	1,804	2,065	-261	-13
469	Johnson & Johnson	Total Neuroscience			USD	Millions	6,085	6,259	6,085	6,259	-174	-3
470	Johnson & Johnson	Darzalex	Daratumumab	Oncology	USD	Millions	572	20	572	20	552	2,760
471	Johnson & Johnson	Imbruvica	Ibrutinib	Oncology	USD	Millions	1,251	689	1,251	689	562	82
472	Johnson & Johnson	Velcade	Bortezomib	Oncology	USD	Millions	1,224	1,333	1,224	1,333	-109	-8
473	Johnson & Johnson	Zytiga	Abiraterone Acetate	Oncology	USD	Millions	2,260	2,231	2,260	2,231	29	1
474	Johnson & Johnson	Other Products			USD	Millions	500	442	500	442	58	13
475	Johnson & Johnson	Total Oncology			USD	Millions	5,807	4,695	5,807	4,695	1,112	24
476	Johnson & Johnson	Invokana/Invokamet	Canagliflozin/ Canagliflozin And Metformin Hcl	Diabetes	USD	Millions	1,407	1,308	1,407	1,308	99	8
477	Johnson & Johnson	Procrit/Eprex	Epoetin Alfa	Blood Disorders	USD	Millions	1,105	1,068	1,105	1,068	37	3
478	Johnson & Johnson	Xarelto	Rivaroxaban	Cardiovascular Diseases	USD	Millions	2,288	1,868	2,288	1,868	420	22
479	Johnson & Johnson	Other Products			USD	Millions	1,596	2,174	1,596	2,174	-578	-27
480	Johnson & Johnson	Total Other Prescription Products			USD	Millions	6,396	6,418	6,396	6,418	-22	0
481	Johnson & Johnson	Total Pharmaceuticals			USD	Millions	33,464	31,430	33,464	31,430	2,034	6
482	Johnson & Johnson	Consumer Health Care			USD	Millions	13,307	13,507	13,307	13,507	-200	-1
483	Johnson & Johnson	Medical Devices			USD	Millions	25,119	25,137	25,119	25,137	-18	0
484	Johnson & Johnson	Total All Divisions			USD	Millions	71,890	70,074	71,890	70,074	1,816	3
485	Mallinckrodt Plc	Acthar	Corticotropin	Autoimmune Disorders	USD	Millions	1,160	1,037	1,160	1,037	123	12
486	Mallinckrodt Plc	Inomax	Nitric Oxide	Respiratory Disorders	USD	Millions	474	185	474	185	289	156
487	Mallinckrodt Plc	Ofirmev	Acetaminophen	Anti-Inflammatory	USD	Millions	284	263	284	263	21	8
488	Mallinckrodt Plc	Therakos Immunotherapy			USD	Millions	208	Not Reported	208	Not Reported	208	Not Reported
489	Mallinckrodt Plc	Hemostasis Products			USD	Millions	43	Not Reported	43	Not Reported	43	Not Reported
490	Mallinckrodt Plc	Others			USD	Millions	132	137	132	137	-5	-4
491	Mallinckrodt Plc	Specialty Brands			USD	Millions	2,301	1,623	2,301	1,623	678	42
492	Mallinckrodt Plc	Hydrocodone (API) And Hydrocodone-Containing Tablets	Hydrocodone Bitartrate	Anti-Inflammatory	USD	Millions	147	167	147	167	-20	-12
493	Mallinckrodt Plc	Oxycodone (Api) And Oxycodone-Containing Tablets	Oxycodone	Anti-Inflammatory	USD	Millions	126	155	126	155	-29	-19
494	Mallinckrodt Plc	Methylphenidate Er	Methylphenidate Hydrochloride	Neurological/Mental Disorders	USD	Millions	104	137	104	137	-33	-24
495	Mallinckrodt Plc	Other Controlled Substances			USD	Millions	468	572	468	572	-104	-18
496	Mallinckrodt Plc	Others			USD	Millions	181	221	181	221	-40	-18
497	Mallinckrodt Plc	Specialty Generics			USD	Millions	1,025	1,252	1,025	1,252	-227	-18
498	Mallinckrodt Plc	Others			USD	Millions	55	49	55	49	6	12
499

Product Sales Data From Annual Reports of Major Pharmaceutical Companies // 2016

Get the Excel version